Kathy Lampl

1.5k total citations · 1 hit paper
34 papers, 742 citations indexed

About

Kathy Lampl is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Kathy Lampl has authored 34 papers receiving a total of 742 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 15 papers in Physiology and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Kathy Lampl's work include Asthma and respiratory diseases (15 papers), Inhalation and Respiratory Drug Delivery (10 papers) and Respiratory and Cough-Related Research (9 papers). Kathy Lampl is often cited by papers focused on Asthma and respiratory diseases (15 papers), Inhalation and Respiratory Drug Delivery (10 papers) and Respiratory and Cough-Related Research (9 papers). Kathy Lampl collaborates with scholars based in United States, United Kingdom and Sweden. Kathy Lampl's co-authors include Sulabha Ramachandran, Bradley E. Chipps, Kevin R. Murphy, Michael Schatz, Robert S. Zeiger, Michael Mellon, Mark Kosinski, Steven E. Nissen, Jeffrey B. Geske and Amy J. Sehnert and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PEDIATRICS.

In The Last Decade

Kathy Lampl

32 papers receiving 708 citations

Hit Papers

Myosin Inhibition in Patients With Obstructive Hypertroph... 2022 2026 2023 2024 2022 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy
    2022 183 citations Milind Y. Desai, Anjali Owens et al. Journal of the American College of Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathy Lampl United States 14 327 266 232 97 70 34 742
Adriana Carolei Italy 9 321 1.0× 452 1.7× 350 1.5× 16 0.2× 147 2.1× 26 1.2k
Nargues Weir United States 18 174 0.5× 282 1.1× 804 3.5× 126 1.3× 110 1.6× 34 1.1k
Bruno Sposato Italy 14 49 0.1× 306 1.2× 398 1.7× 54 0.6× 62 0.9× 56 639
Susan Boklage United States 15 85 0.3× 43 0.2× 154 0.7× 46 0.5× 139 2.0× 43 672
Ebymar Arismendi Spain 12 37 0.1× 245 0.9× 250 1.1× 35 0.4× 86 1.2× 43 482
Ashokakumar M. Patel United States 10 94 0.3× 82 0.3× 212 0.9× 54 0.6× 47 0.7× 12 369
Stefania Menoni Italy 14 37 0.1× 106 0.4× 85 0.4× 36 0.4× 61 0.9× 28 444
G. Turner Australia 12 70 0.2× 259 1.0× 243 1.0× 277 2.9× 311 4.4× 29 906
Ju Hyun Lee South Korea 14 32 0.1× 74 0.3× 113 0.5× 77 0.8× 82 1.2× 23 638
Becky L. M. Carpenter United States 10 158 0.5× 67 0.3× 221 1.0× 237 2.4× 132 1.9× 12 547

Countries citing papers authored by Kathy Lampl

Since Specialization
Citations

This map shows the geographic impact of Kathy Lampl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathy Lampl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathy Lampl more than expected).

Fields of papers citing papers by Kathy Lampl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathy Lampl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathy Lampl. The network helps show where Kathy Lampl may publish in the future.

Co-authorship network of co-authors of Kathy Lampl

This figure shows the co-authorship network connecting the top 25 collaborators of Kathy Lampl. A scholar is included among the top collaborators of Kathy Lampl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathy Lampl. Kathy Lampl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Desai, Milind Y., Sara Saberi, Jeffrey B. Geske, et al.. (2025). Long-Term Response of Obstructive Hypertrophic Cardiomyopathy Patients to Mavacamten Based on Sex. JACC Heart Failure. 13(6). 1037–1040. 2 indexed citations
2.
Desai, Milind Y., Kathy Wolski, Jeffrey B. Geske, et al.. (2025). Long-Term Favorable Cardiac Remodeling in Obstructive Hypertrophic Cardiomyopathy Patients Treated With Mavacamten for Up to 128 Weeks. JACC. Cardiovascular imaging. 18(12). 1300–1311.
3.
Desai, Milind Y., Kathy Wolski, Anjali Owens, et al.. (2024). Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results From VALOR-HCM. Circulation. 151(19). 1378–1390. 14 indexed citations
4.
Desai, Milind Y., Anjali Owens, Jeffrey B. Geske, et al.. (2022). Dose-Blinded Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Outcomes Through 32 Weeks. Circulation. 147(11). 850–863. 53 indexed citations
5.
Cremer, Paul, Jeffrey B. Geske, Anjali Owens, et al.. (2022). Myosin Inhibition and Left Ventricular Diastolic Function in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Insights From the VALOR-HCM Study. Circulation Cardiovascular Imaging. 15(12). e014986–e014986. 41 indexed citations
6.
Cremer, Paul, Jeffrey B. Geske, Anjali Owens, et al.. (2022). Abstract 12577: Effect of Mavacamten on Diastolic Function in Patients With Obstructive Hypertrophic Cardiomyopathy: Insights From the VALOR-HCM Study. Circulation. 146(Suppl_1). 1 indexed citations
7.
Desai, Milind Y., Anjali Owens, Jeffrey B. Geske, et al.. (2022). Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy. Journal of the American College of Cardiology. 80(2). 95–108. 183 indexed citations breakdown →
8.
Desai, Milind Y., Kathy Wolski, Anjali Owens, et al.. (2021). Study design and rationale of VALOR-HCM: evaluation of mavacamten in adults with symptomatic obstructive hypertrophic cardiomyopathy who are eligible for septal reduction therapy. American Heart Journal. 239. 80–89. 38 indexed citations
9.
Meltzer, Eli O., et al.. (2015). Efficacy and safety of budesonide administered by pressurized metered-dose inhaler in children with asthma. Annals of Allergy Asthma & Immunology. 115(6). 516–522. 7 indexed citations
10.
Nyberg, Fredrik, Johan Askling, Niklas Berglind, et al.. (2015). Using epidemiological registry data to provide background rates as context for adverse events in a rheumatoid arthritis drug development program: a coordinated approach. Pharmacoepidemiology and Drug Safety. 24(11). 1121–1132. 7 indexed citations
11.
Spindler, Alberto, Juan J. Gómez‐Reino, Edward J. Fudman, et al.. (2013). Oskira-3: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study Of 2 Dosing Regimens Of Fostamatinib In Rheumatoid Arthritis Patients With An Inadequate Response To a Tumor Necrosis Factor-alpha Antagonist. Data Archiving and Networked Services (DANS). 1 indexed citations
12.
Brown, Randall W., Christopher D. O’Brien, Ubaldo J. Martin, Tom Uryniak, & Kathy Lampl. (2012). Long-term safety and asthma control measures with a budesonide/formoterol pressurized metered-dose inhaler in African American asthmatic patients: A randomized controlled trial. Journal of Allergy and Clinical Immunology. 130(2). 362–367.e9. 18 indexed citations
13.
Zeiger, Robert S., Michael Mellon, Bradley E. Chipps, et al.. (2011). Test for Respiratory and Asthma Control in Kids (TRACK): Clinically meaningful changes in score. Journal of Allergy and Clinical Immunology. 128(5). 983–988. 46 indexed citations
14.
15.
Welch, Michael J., Mona L. Martin, Paul V. Williams, et al.. (2010). Evaluation of Inhaler Device Technique in Caregivers of Young Children with Asthma. Pediatric Allergy Immunology and Pulmonology. 23(2). 113–120. 11 indexed citations
16.
Murphy, Kevin R., Robert S. Zeiger, Mark Kosinski, et al.. (2009). Test for Respiratory and Asthma Control in Kids (TRACK): A caregiver-completed questionnaire for preschool-aged children. Journal of Allergy and Clinical Immunology. 123(4). 833–839.e9. 118 indexed citations
17.
Leidy, Nancy Kline, Benjamín Gutiérrez, Kathy Lampl, Tom Uryniak, & Christopher D. O’Brien. (2009). Can Patients With Asthma Feel Inhaler Therapy Working Right Away? Two Clinical Trials Testing the Effect of Timing of Assessment on Patient Perception. Journal of Asthma. 46(10). 1006–1012. 14 indexed citations
18.
Pearlman, David S., Peter S. Creticos, Kathy Lampl, et al.. (2005). Once-daily ciclesonide is effective and well-tolerated in adult and adolescent patients with mild-to-moderate asthma. Journal of Allergy and Clinical Immunology. 115(2). S212–S212. 2 indexed citations
19.
Pearlman, David S., Kathy Lampl, Paul Dowling, Christopher J. Miller, & Catherine M. Bonuccelli. (2000). Effectiveness and tolerability of zafirlukast for the treatment of asthma in children. Clinical Therapeutics. 22(6). 732–747. 37 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adriana Carolei Breakdown of academic impact, for papers by Nargues Weir Breakdown of academic impact, for papers by Bruno Sposato Breakdown of academic impact, for papers by Susan Boklage Breakdown of academic impact, for papers by Ebymar Arismendi Breakdown of academic impact, for papers by Ashokakumar M. Patel Breakdown of academic impact, for papers by Stefania Menoni Breakdown of academic impact, for papers by G. Turner Breakdown of academic impact, for papers by Ju Hyun Lee Breakdown of academic impact, for papers by Becky L. M. Carpenter
Rankless by CCL
2026